Basics Arcutis Biotherapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.40% Avg Daily Range (30 D): $0.47 | 2.43% Avg Daily Range (90 D): $0.42 | 2.51% Institutional Daily Volume Avg Daily Volume: 1.11M Avg Daily Volume (30 D): 1.55M Avg Daily Volume (90 D): 1.49M Trade Size Avg Trade Size (Sh.): 102 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 1,999 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $3.1M Avg Inst. Trade (90 D): $2.86M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.46M Avg Closing Trade (30 D): $4.17M Avg Closing Trade (90 D): $3.65M Avg Closing Volume: 198.47K     News Oct 3, 2025 @ 8:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Arcutis Biotherapeutics, Inc. Sep 29, 2025 @ 8:00 PM Arcutis Biotherapeutics to Host Virtual Investor D... Source: Arcutis Biotherapeutics, Inc. Sep 5, 2025 @ 8:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Arcutis Biotherapeutics, Inc. Sep 3, 2025 @ 5:00 PM PDE4B Inhibitor Market Poised for Strong Growth by... Source: Delveinsight Aug 27, 2025 @ 8:26 AM 3 Biotech Catalysts Present Major Opportunity Source: Nathan Reiff Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.74 $-.13 $-.2 Diluted EPS $-.74 $-.13 $-.2 Revenue $ 263.47M $ 81.5M $ 65.85M Gross Profit $ 234.74M $ 74.01M $ 57.02M Net Income / Loss $ -93.27M $ -15.89M $ -25.06M Operating Income / Loss $ -85.84M $ -14.61M $ -24.53M Cost of Revenue $ 28.73M $ 7.49M $ 8.83M Net Cash Flow $ -11.91M $ 19.13M $ -18.24M PE Ratio